SHOULD WE OFFER MULTI-GENE TESTING TO ALL PATIENTS WITH BREAST CANCER: A COST-EFFECTIVENESS ANALYSIS
dc.contributor.author | Sun, L | |
dc.contributor.author | Brentnall, A | |
dc.contributor.author | Patel, S | |
dc.contributor.author | Buist, D | |
dc.contributor.author | Bowles, E | |
dc.contributor.author | Evans, DG | |
dc.contributor.author | Eccles, D | |
dc.contributor.author | Hopper, J | |
dc.contributor.author | Li, S | |
dc.contributor.author | Duffy, S | |
dc.contributor.author | Cuzick, J | |
dc.contributor.author | dos-Santos-Silva, I | |
dc.contributor.author | Sadique, Z | |
dc.contributor.author | Yang, L | |
dc.contributor.author | Legood, R | |
dc.contributor.author | Manchanda, R | |
dc.date.accessioned | 2020-10-15T15:21:33Z | |
dc.date.available | 2020-10-15T15:21:33Z | |
dc.date.issued | 2019-11 | |
dc.identifier.issn | 1048-891X | |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/67596 | |
dc.format.extent | A31 - A32 | |
dc.title | SHOULD WE OFFER MULTI-GENE TESTING TO ALL PATIENTS WITH BREAST CANCER: A COST-EFFECTIVENESS ANALYSIS | en_US |
dc.type | Conference Proceeding | en_US |
dc.identifier.doi | 10.1136/ijgc-2019-ESGO.31 | |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000523502500032&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 29 | en_US |
Files in this item
This item appears in the following Collection(s)
-
Centre for Cancer Prevention [1181]